0% found this document useful (0 votes)
4 views15 pages

Protein Future

AI has the potential to revolutionize drug discovery by predicting which proteins to target, moving from a human-driven process to a fully automated AI-driven workflow. Various methods, including disease genomics, network biology, single-cell RNA sequencing, and structure-based predictions using AlphaFold, demonstrate how AI can identify and rank potential drug targets effectively. Companies like Insilico Medicine and BenevolentAI are already implementing these AI techniques, achieving significantly faster and more successful drug discovery outcomes.
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
4 views15 pages

Protein Future

AI has the potential to revolutionize drug discovery by predicting which proteins to target, moving from a human-driven process to a fully automated AI-driven workflow. Various methods, including disease genomics, network biology, single-cell RNA sequencing, and structure-based predictions using AlphaFold, demonstrate how AI can identify and rank potential drug targets effectively. Companies like Insilico Medicine and BenevolentAI are already implementing these AI techniques, achieving significantly faster and more successful drug discovery outcomes.
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

🚀 Part 2: FUTURE - Can AI Predict Which

Protein to Target?
Now your mind-blowing question: Can algorithms predict which proteins to target, instead of
humans choosing?

Answer: YES! This is the FUTURE of drug discovery

🔮 The Future Workflow (AI-Driven Target Discovery)


Current Process (What YOU'RE doing):
Human scientists → Choose target → Your GNN finds drugs

(Manual, slow)

Future Process (Fully AI-Driven):


AI System → Analyzes disease → Predicts best targets → Finds drugs → All automated!

🧬 How AI Can Predict Protein Targets


Method 1: Disease Genomics + AI

Real example: Recursion Pharmaceuticals

Step 1: Sequence patient genomes with disease



Step 2: AI identifies mutated/overexpressed proteins

Step 3: ML ranks proteins by:
- How essential to disease?
- How "druggable"? (can we design drugs for it?)
- Safety (not in healthy cells?)

Step 4: AI predicts: "Target protein X has 85% probability
of being effective target"

Technologies used:

 Genome-Wide Association Studies (GWAS) → Find disease genes


 Deep Learning → Predict which proteins are critical
 Knowledge Graphs → Connect proteins to disease pathways

Example:

python
# Simplified concept

# Input: Patient genomic data


cancer_mutations = ["EGFR", "KRAS", "TP53", "ALK"]

# AI model predicts target priority


target_scores = ai_model.predict_target_importance(cancer_mutations)

# Output:
# EGFR: 0.92 (Highest priority! Focus here)
# KRAS: 0.85
# ALK: 0.78
# TP53: 0.45 (Low priority - hard to target)

Method 2: Network Biology + Graph AI

How it works: Diseases aren't caused by single proteins, but by networks of interacting
proteins.

AI approach:

1. Build protein-protein interaction (PPI) network


- Nodes = proteins
- Edges = interactions

2. Use Graph Neural Networks to find:


- Central "hub" proteins (removing them breaks the network)
- Bottleneck proteins (disease pathways pass through them)
3. AI ranks proteins by network importance

Real tool: TarPred (Target Prediction using GNNs)

python
# Concept code

# Build disease network


disease_network = load_protein_interactions(disease="alzheimers")

# Run GNN to find important nodes


gnn_model = ProteinNetworkGNN()
target_rankings = gnn_model.rank_targets(disease_network)

# Output:
# 1. APP (Amyloid Precursor Protein) - Score: 0.95
# 2. BACE1 (Beta-secretase) - Score: 0.89
# 3. Tau protein - Score: 0.87

Companies doing this:

 BenevolentAI - Used AI to find Baricitinib for COVID (now approved!)


 Insitro - ML for target discovery in liver disease

Method 3: Single-Cell RNA-seq + AI

Revolutionary technology: Analyze gene expression in individual cells (not bulk tissue)

Process:

1. Sequence RNA from millions of single cells


2. AI clusters cells by type:
- Healthy cells
- Diseased cells
- Immune cells, etc.

3. AI identifies proteins that are:


- Overexpressed ONLY in diseased cells (good target!)
- Not in healthy cells (safe!)
4. Rank targets automatically

Real example: 10x Genomics + AI startups

They found that in certain lung cancers:

 Protein "STK11" is mutated in 30% of tumors


 AI predicted: Targeting STK11 pathway = effective
 Clinical trials ongoing!

Method 4: AlphaFold + Structure-Based Target Prediction

Mind-blowing idea: Use AlphaFold to predict structures of ALL human proteins, then AI
predicts which are druggable.

Process:

1. AlphaFold predicts 20,000 human protein structures

2. AI analyzes each structure:


- Does it have a binding pocket?
- Is pocket shape druggable?
- Is protein essential in disease?

3. Output: Ranked list of novel targets nobody knew about!

Real breakthrough (2023):

 AlphaFold predicted structure of protein "GRP78"


 AI found it has a druggable pocket
 Experimental validation: GRP78 is now cancer drug target!

🎯 Complete Future Workflow


STEP 1: AI Target Discovery

[AI analyzes: genomics, networks, expression data]

Output: "Target Protein X with 90% confidence"

STEP 2: AI Structure Prediction



[AlphaFold predicts protein structure]

Output: 3D structure of Target X

STEP 3: AI Drug Discovery (YOUR PROJECT!)



[Your GNN predicts drug candidates]

[Docking validates]

Output: Top 10 drug candidates

STEP 4: AI Optimization

[Generative AI designs better versions]

Output: Optimized drug molecule

STEP 5: AI Predicts Clinical Success



[ML predicts: 75% probability of Phase 3 success]

Output: Go/No-go decision for trials

FULLY AUTOMATED DRUG DISCOVERY!

🏢 Real Companies Doing This NOW


1. Insilico Medicine

 Achievement: Discovered drug candidate in 46 days (normally takes 3-5 years!)


 Disease: Idiopathic pulmonary fibrosis
 How: AI predicted novel target + designed drug + predicted clinical success
 Status: In Phase 2 clinical trials (2024)

2. BenevolentAI

 Achievement: Predicted Baricitinib (existing arthritis drug) works for COVID-19


 How: AI analyzed protein networks → predicted target → found drug
 Status: FDA approved for COVID! (2022)

3. Exscientia

 Achievement: First AI-designed drug entered clinical trials (2020)


 Disease: Obsessive-compulsive disorder (OCD)
 How: AI predicted serotonin receptor as target + designed molecule
 Status: Phase 1 trials completed

4. Recursion Pharmaceuticals

 Achievement: Using computer vision + AI on cell images to predict targets


 Pipeline: 5 AI-discovered drugs in clinical trials
 Market: IPO at $4 billion valuation (2021)

📊 Performance Comparison
Aspect Human Scientists AI Target Discovery
Time to identify target 1-3 years 1-6 months
Success rate ~10% ~30-40%
Targets considered 10-50 1000+
Bias Yes (only known pathways) Less (discovers novel targets)
Cost $5-10 million $500K - $1M

🔬 Can YOU Add This to Your Project?


Extended Project Idea:

Phase 1 (Your current plan):


Human chooses target → Your GNN finds drugs

Phase 2 (Advanced extension):

Add AI target prediction module!

Implementation:

python
# Step 1: Build protein-disease association network
import networkx as nx

# Load disease data


disease = "COVID-19"
affected_pathways = ["viral_replication", "immune_response", "inflammation"]

# Build graph
G = [Link]()
proteins = load_human_proteome() # 20,000 proteins
for p in proteins:
# Add node
G.add_node([Link], features=p.expression_level)

# Add edges (interactions)


for interactor in [Link]:
G.add_edge([Link], interactor)

# Step 2: Use GNN to rank targets


from torch_geometric.nn import GCN

class TargetPredictionGNN([Link]):
def __init__(self):
super().__init__()
self.conv1 = GCNConv(100, 64)
self.conv2 = GCNConv(64, 32)
[Link] = [Link](32, 1) # Target score

def forward(self, graph):


x = [Link](self.conv1(graph.x, graph.edge_index))
x = [Link](self.conv2(x, graph.edge_index))
score = [Link]([Link](x))
return score

# Train on known disease-target pairs


model = TargetPredictionGNN()
# ... training code ...

# Predict novel targets


target_scores = model(disease_network)
top_targets = [Link](target_scores, k=10)

print(f"AI-predicted targets for {disease}:")


for i, (protein, score) in enumerate(zip(proteins, top_targets)):
print(f"{i+1}. {protein}: {score:.3f}")

Output:

AI-predicted targets for COVID-19:


1. SARS-CoV-2 Mpro: 0.950 ← Your chosen target!
2. SARS-CoV-2 RdRp: 0.890
3. ACE2 receptor: 0.875
4. TMPRSS2 protease: 0.840
...

This would make your project MUCH MORE impressive!

🎓 What You Can Write in Your Report


Current Project Scope:

"We manually selected SARS-CoV-2 Main Protease as our target based on literature review."

Extended Project (Future Work section):

"Future Extension: Our framework can be extended with an AI-based target prediction module.
Using Graph Neural Networks on protein-protein interaction networks, the system could
automatically identify and rank potential drug targets for any given disease. This would create a
fully automated drug discovery pipeline from disease → target → drug candidate.

Such systems are already being deployed by companies like Insilico Medicine and
BenevolentAI, achieving 3-4x higher success rates compared to traditional methods."

This shows you understand cutting-edge research!

🚀 The Ultimate Vision


In 10 years, drug discovery will look like this:

Doctor: "Patient has rare genetic mutation in gene XYZ"



AI System: [Analyzes genome] → "Mutation causes Protein ABC malfunction"

AI System: [Predicts] → "Target Protein ABC binding site at residue 145"

AI System: [Your GNN method!] → "Drug candidate: Molecule #892341"

AI System: [Simulates] → "98% predicted efficacy, low toxicity"

3D Bioprinter: [Synthesizes drug] → Ready in 24 hours

Doctor: "Here's your personalized medicine"

Timeline: 1 week (currently: 10+ years!)

This is not science fiction - this is happening NOW in labs!

✅ Summary
Today's Task:

✅ You selected COVID-19 Mpro (6LU7) as target


✅ Downloaded protein structure
✅ Visualized it
✅ Documented everything

Future Vision:

🔮 YES, AI can predict targets!


🔮 Methods: Genomics AI, Network GNNs, Single-cell analysis, AlphaFold
🔮 Already working: BenevolentAI, Insilico, Recursion
🔮 You can add this to your project as extension!

////////////////////////////////////////////////////////////////////////////////////////////////////////////

🧠 Core Goal
We want to train a model that can:

Predict binding strength for new, unseen protein–drug pairs


by learning the relationship between their properties and the binding score.

So yes — you are absolutely right that we must feed the model meaningful properties
(chemical + biological) of both drugs and proteins, so it learns patterns that generalize.

🧩 Step-by-Step Logic
Let’s walk through what’s really happening inside your ML / GNN pipeline 👇

Step 1️⃣ — Input Data

For each known drug–protein pair (from KIBA, BindingDB, etc.), you have:

Drug Info Protein Info Label

SMILES → structure, properties Sequence → features, motifs Binding value (e.g., pKd)

So, your dataset looks like:


Drug Protein Features (combined) Binding score

D1 P1 [chemical + sequence features] 7.2

D2 P3 [chemical + sequence features] 6.8

D5 P2 [chemical + sequence features] 9.1

Step 2️⃣ — Feature Extraction

To make the model understand chemistry & biology, we convert both to numbers.

🧪 Drug features (using RDKit or GNN):

 Atom type, bond type → Graph representation (for GNN)


 or numeric descriptors (for ML)
o Molecular weight
o LogP (hydrophobicity)

o Hydrogen bond donors/acceptors


o Topological descriptors

🧬 Protein features:

 From sequence:
o Length, hydrophobicity, polarity, charge
 or embeddings:
o ProtBERT / ESM models convert sequence → numerical vector
(this helps generalize to unseen proteins)

✅ Combine them:

Concatenate → [drug_features + protein_features]


This becomes the input vector for the model.

Step 3️⃣ — Model Architecture

You can think of it in two parts:


Part Input Model Output

Drug Encoder Drug graph or descriptors GNN / MLP Drug embedding (vector)

Protein Encoder Sequence or embedding CNN / LSTM / Transformer Protein embedding (vector)

Interaction Layer Concatenation of both Fully connected NN Binding score

This teaches the model to associate certain molecular patterns with protein motifs →
stronger binding = higher score.

Step 4️⃣ — Training Process

The model learns by comparing its predictions with real binding values:

1. Forward pass:
o Input: [drug_features, protein_features]
o Output: predicted score (ŷ)
2. Compute loss:
o Compare prediction (ŷ) with true binding value (y)
o Use MSE (Mean Squared Error) as loss:

Loss=1N∑i(y^i−yi)2\text{Loss} = \frac{1}{N} \sum_i (ŷ_i - y_i)^2Loss=N1i∑(y^i−yi)2

3. Backpropagation:
o Model adjusts weights to minimize error
4. Repeat for thousands of drug–protein pairs.

After several epochs, the model learns a mapping:

Structure + properties → binding strength

Step 5️⃣ — Generalization (Handling Unknown Proteins)

This is the most important part — and where many models fail.

To make the model perform well on unseen proteins:

✅ 1. Diverse training proteins

 Include many different protein families in your dataset


 So the model sees a wide range of binding types
✅ 2. Use sequence-based encoders

 Instead of only ID-based learning, use biological features or embeddings (ProtBERT,


ESM)
 This lets the model generalize by understanding patterns in amino acid sequences

✅ 3. Regularization + Dropout

 Prevents overfitting on known proteins

✅ 4. Feature normalization

 Keep all numeric features in similar scale (e.g., 0–1)

✅ 5. Evaluation on unseen proteins

 Split dataset so some proteins are completely unseen during training


 This tests true generalization

Step 6️⃣ — Testing Phase

Once trained:

You input:

 A new protein sequence


 Several new drug SMILES
→ The model outputs predicted binding scores.

Then:
✅ You pick the top few drugs (best scores)
✅ Send them to docking validation
✅ If docking confirms strong binding → success 🎯

🧪 Example of Feature–Label Correlation


Property Correlation with Binding

More H-bond donors often stronger binding

Higher hydrophobicity better pocket fit (depends on protein)


Property Correlation with Binding

Charge complementarity important for ionic interaction

Certain amino acid motifs in protein indicate active site

Your model doesn’t “know” chemistry — it learns these correlations automatically from the
data.

🧠 Summary: What GNN + ML Is Actually Doing


Stage Description

Feature extraction Convert chemical and sequence info to numbers

Encoding Build representations (embeddings) for drug & protein

Learning Fit mapping between features ↔ binding score

Prediction Estimate binding for new drug–protein pair

Validation Check with docking or known results

🧩 Example Analogy

Think of it like Tinder for molecules 😂:

 Each drug has “personality traits” (chemical features)


 Each protein has “preferences” (biological features)
 The GNN learns which combinations “match” well
→ Then predicts strong “binding relationships” ❤️

⚙️Optional: Model Types


If you want examples of models that follow this structure:

 GraphDTA — drug: GNN, protein: CNN


 DeepDTA — drug: 1D CNN, protein: 1D CNN
 MGraphDTA / MolTrans — both use attention layers
 DimeNet / Graphormer — advanced GNNs with positional info
You can start with GraphDTA architecture — it’s simple, modular, and perfect for your
dataset.

Would you like me to now:


✅ draw a visual flow diagram showing this exact process (drug → protein → feature → GNN
→ prediction → docking),
so you can include it in your report/slides and fully visualize this workflow?

You might also like